Delic’s ‘Family-First’ Program At Ketamine Wellness Centers Offers Support For Patients’ Families And Loved Ones Nov 24, 2021
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus Nov 24, 2021
CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
Can EEG Changes Help Predict Long-Term Response To Ketamine Treatment For Depression? Entheon Study Will Find Out Nov 15, 2021
